HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 275, Issue 33, 25095-25101, August 18, 2000

This Article Full Text Full Text (PDF) All Versions of this Article: 275/33/25095    most recent M004251200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petropoulos, H. Articles by Skerjanc, I. S. Search for Related Content PubMed PubMed Citation Articles by Petropoulos, H. Articles by Skerjanc, I. S. Social Bookmarking                      What's this?

Analysis of the Inhibition of MyoD Activity by ITF-2B and Full-length E12/E47^*

Helen Petropoulos and Ilona S. Skerjanc^§

From the Department of Biochemistry, University of Western Ontario, London, Ontario N6A 5C1, Canada

MyoD heterodimerizes with E type factors (E12/E47 and ITF-2A/ITF-2B) and binds E box sequences within promoters of muscle-specific genes. In transient transfection assays, MyoD activates transcription in the presence of ITF-2A but not ITF-2B, which contains a 182-amino acid N-terminal extension. The first 83 amino acids of the inhibitory N terminus of ITF-2B show high sequence homology to the N terminus of full-length E12/E47. Previous studies that showed activation of MyoD by E12 used an artificially N-terminally truncated form. Here we show that the full-length form of E12 inhibits MyoD function. A conserved -helix motif, capable of interacting with the transcriptional machinery, was not essential for inhibition. Furthermore, the fusion of N-terminal ITF-2B sequences or non-inhibiting ITF-2A sequences to truncated E12 was sufficient in converting the activator into an inhibitor. Overexpression of ITF-2B did not inhibit C2C12 myogenesis or affect levels of endogenous muscle gene expression, consistent with the finding that inhibitory E type proteins are present in muscle. Furthermore, we found that MyoD co-transfected with either ITF-2B or ITF-2A converted fibroblasts into myoblasts with the same frequency. Our findings suggest that the ability of E type proteins to inhibit MyoD activity is dependent on the context of the E box.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. B. Laursen, E. Mielke, P. Iannaccone, and E.-M. Fuchtbauer Mechanism of Transcriptional Activation by the Proto-oncogene Twist1 J. Biol. Chem., November 30, 2007; 282(48): 34623 - 34633. [Abstract] [Full Text] [PDF]

				A. G. Ridgeway, H. Petropoulos, S. Wilton, and I. S. Skerjanc Wnt Signaling Regulates the Function of MyoD and Myogenin J. Biol. Chem., October 13, 2000; 275(42): 32398 - 32405. [Abstract] [Full Text] [PDF]